Skip to main content

NCBiotech Awards $3.6 Million in Loans, Grants in Latest Quarter

The North Carolina Biotechnology Center awarded 47 loans and grants totaling $3.6 million to universities, bioscience companies and other entities in the fourth quarter of its 2016-2017 fiscal year ending June 30.

NCBiotech Funding Supports Portable Cervical Cancer Device Development

A $75,000 grant from the North Carolina Biotechnology Center is helping Duke University researchers develop a cervical cancer screening tool that women everywhere might be able to use on themselves.

Seqirus Meets New Milestone in Pandemic Preparedness

Seqirus, the Holly Springs vaccine manufacturer, recently achieved another major milestone in its efforts to support the U.S. government’s pandemic preparedness efforts, showing it can now produce 150 million doses of a mammalian cell-derived flu vaccine in the first six months of pandemic declaration.

Piedmont Revs Up Product Innovations for Pets, People

Piedmont Animal Health is one of Greensboro's shining life science stars with a successful stragegy of being fast to the market with innovative products that are mostly conceived in its own labs.

Aerie Pharmaceuticals Expanding in Durham

California-based Aerie Pharmaceuticals, a clinical-stage company developing new treatments for glaucoma and other eye diseases, is expanding its R&D operations in Durham as some of its drug candidates move closer to commercialization.

Cempra, Melinta Therapeutics to Merge

Chapel Hill-based Cempra, a publicly held pharmaceutical company developing treatments for infectious diseases, plans to merge with privately held Melinta Therapeutics, an antibiotics developer based in New Haven, Conn.

Pfizer Boosts North Carolina Footprint with $100 Million Expansion

Pfizer, the global pharmaceutical giant, will expand its vaccine-manufacturing plant in Sanford with a $100 million investment in gene therapy that will add 40 jobs to its workforce.

Lifestar Pharma Enters NC with Purchase of Durham Facility

Citing the Research Triangle region’s prevalence of top talent and nationally ranked research universities, New Jersey-based Lifestar Pharma has purchased a Durham building for a new R&D and manufacturing operation.

LabCorp to Acquire Chiltern for $1.2 Billion

Burlington-based LabCorp, the global life sciences company built on laboratory diagnostic testing, anounced plans to acquire Chiltern International, a privately held contract research organization (CRO) that has its North American headquarters in Wilmington, for about $1.2 billion.

BioFluidica Raises $4.1M for Cancer Diagnosis Development

BioFluidica, a Chapel Hill company developing a product using liquid biopsies for cancer detection, has raised $4.1 million in a private equity offering. 

Pages

Subscribe to RSS - Life Sciences